Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes-Reference-Cited by-同舟云学术

Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes

Published:2023-03 Issue:6 Volume:186 Page:1127-1143.e18
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Rahim Maha K.,Okholm Trine Line H.,Jones Kyle B.,McCarthy Elizabeth E.,Liu Candace C.,Yee Jacqueline L.,Tamaki Stanley J.,Marquez Diana M.,Tenvooren Iliana,Wai Katherine,Cheung Alexander,Davidson Brittany R.,Johri Vrinda,Samad Bushra,O’Gorman William E.,Krummel Matthew F.,van Zante Annemieke,Combes Alexis J.,Angelo Michael,Fong Lawrence,Algazi Alain P.,Ha Patrick,Spitzer Matthew H.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference95 articles.

1. Systemic immunity in cancer;Hiam-Galvez;Nat. Rev. Cancer,2021

2. Systemic immunity is required for effective cancer immunotherapy;Spitzer;Cell,2017

3. Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy;Fransen;JCI Insight,2018

4. The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes;Dammeijer;Cancer Cell,2020

5. Clonal replacement of tumor-specific T cells following PD-1 blockade;Yost;Nat. Med.,2019

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration;Current Gene Therapy;2025-04

2. An ultra-long-acting L-asparaginase synergizes with an immune checkpoint inhibitor in starvation-immunotherapy of metastatic solid tumors;Biomaterials;2025-01

3. Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells;Translational Oncology;2024-10

4. Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer;Cancers;2024-09-11

5. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09